在线课堂:健康相关生存质量的测定与评价

2015-06-04 MedSci MedSci原创

为什么要讲健康相关的生存质量呢?要理解疾病的决定因素,以及达到合理的治疗的卫生保健模式,医学模式必须考虑到病人、病人生活在其中的环境以及有社会设计来对付疾病的破坏作用的补充系统,即医生的作用和卫生保健制度。-Engel医学模式转变的要求:生物医学模式--生物心理-社会医学模式新的医学观影响疾病的诊断,治疗与预后对的判断如何体现以“患者为中心的医学模式”、什么叫“4P医学”,听MedSci学术总监张

为什么要讲健康相关的生存质量呢?

要理解疾病的决定因素,以及达到合理的治疗的卫生保健模式,医学模式必须考虑到病人、病人生活在其中的环境以及有社会设计来对付疾病的破坏作用的补充系统,即医生的作用和卫生保健制度。
-Engel

医学模式转变的要求:
  • 生物医学模式--生物心理-社会医学模式
  • 新的医学观影响疾病的诊断,治疗与预后对的判断
如何体现以“患者为中心的医学模式”、什么叫“P4医学”,听MedSci学术总监张博士为您解析健康相关生存质量的测定与评价。




······

一共8节课:

前沿:健康相关生存质量的测定与评价课程介绍

1.健康相关生存质量的测定与评价(1):生存质量产生的背景与发展 
2.健康相关生存质量的测定与评价(2):生存质量概念及内涵发展        
3.健康相关生存质量的测定与评价(3):通用量表介绍     
4.健康相关生存质量的测定与评价(4):专用量表介绍
5.健康相关生存质量的测定与评价(5):量表的效度评价
6.健康相关生存质量的测定与评价(6):量表的信度、灵敏度和反应度评价
7.健康相关生存质量的测定与评价(7):量表应用案例-生存质量为主要发表
8.健康相关生存质量的测定与评价(8):量表应用案例-生存质量作为一个指标

上线时间:已正式上线

温馨提示:MedSci 医学APP(直接在应用商店搜索MedSci医学/资讯便可下载),第一时间获取课程资料,并享受收费课程50%折扣

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1662216, encodeId=1fc0166221629, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Sep 14 08:33:00 CST 2015, time=2015-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749047, encodeId=09c21e49047f0, content=<a href='/topic/show?id=b7c069022a5' target=_blank style='color:#2F92EE;'>#生存质量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69022, encryptionId=b7c069022a5, topicName=生存质量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ad36217923, createdName=kksonne, createdTime=Tue Mar 29 09:33:00 CST 2016, time=2016-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444120, encodeId=93ec1444120b8, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Sat Jun 06 08:33:00 CST 2015, time=2015-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26025, encodeId=d6452602589, content=热心期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Fri Jun 05 06:34:00 CST 2015, time=2015-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26009, encodeId=383e26009b3, content=太好了,期待!, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Thu Jun 04 19:55:00 CST 2015, time=2015-06-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1662216, encodeId=1fc0166221629, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Sep 14 08:33:00 CST 2015, time=2015-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749047, encodeId=09c21e49047f0, content=<a href='/topic/show?id=b7c069022a5' target=_blank style='color:#2F92EE;'>#生存质量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69022, encryptionId=b7c069022a5, topicName=生存质量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ad36217923, createdName=kksonne, createdTime=Tue Mar 29 09:33:00 CST 2016, time=2016-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444120, encodeId=93ec1444120b8, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Sat Jun 06 08:33:00 CST 2015, time=2015-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26025, encodeId=d6452602589, content=热心期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Fri Jun 05 06:34:00 CST 2015, time=2015-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26009, encodeId=383e26009b3, content=太好了,期待!, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Thu Jun 04 19:55:00 CST 2015, time=2015-06-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1662216, encodeId=1fc0166221629, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Sep 14 08:33:00 CST 2015, time=2015-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749047, encodeId=09c21e49047f0, content=<a href='/topic/show?id=b7c069022a5' target=_blank style='color:#2F92EE;'>#生存质量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69022, encryptionId=b7c069022a5, topicName=生存质量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ad36217923, createdName=kksonne, createdTime=Tue Mar 29 09:33:00 CST 2016, time=2016-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444120, encodeId=93ec1444120b8, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Sat Jun 06 08:33:00 CST 2015, time=2015-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26025, encodeId=d6452602589, content=热心期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Fri Jun 05 06:34:00 CST 2015, time=2015-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26009, encodeId=383e26009b3, content=太好了,期待!, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Thu Jun 04 19:55:00 CST 2015, time=2015-06-04, status=1, ipAttribution=)]
    2015-06-06 huagfeg
  4. [GetPortalCommentsPageByObjectIdResponse(id=1662216, encodeId=1fc0166221629, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Sep 14 08:33:00 CST 2015, time=2015-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749047, encodeId=09c21e49047f0, content=<a href='/topic/show?id=b7c069022a5' target=_blank style='color:#2F92EE;'>#生存质量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69022, encryptionId=b7c069022a5, topicName=生存质量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ad36217923, createdName=kksonne, createdTime=Tue Mar 29 09:33:00 CST 2016, time=2016-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444120, encodeId=93ec1444120b8, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Sat Jun 06 08:33:00 CST 2015, time=2015-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26025, encodeId=d6452602589, content=热心期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Fri Jun 05 06:34:00 CST 2015, time=2015-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26009, encodeId=383e26009b3, content=太好了,期待!, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Thu Jun 04 19:55:00 CST 2015, time=2015-06-04, status=1, ipAttribution=)]
    2015-06-05 午夜星河

    热心期待

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1662216, encodeId=1fc0166221629, content=<a href='/topic/show?id=6a426545472' target=_blank style='color:#2F92EE;'>#测定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65454, encryptionId=6a426545472, topicName=测定)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Mon Sep 14 08:33:00 CST 2015, time=2015-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749047, encodeId=09c21e49047f0, content=<a href='/topic/show?id=b7c069022a5' target=_blank style='color:#2F92EE;'>#生存质量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69022, encryptionId=b7c069022a5, topicName=生存质量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ad36217923, createdName=kksonne, createdTime=Tue Mar 29 09:33:00 CST 2016, time=2016-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444120, encodeId=93ec1444120b8, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Sat Jun 06 08:33:00 CST 2015, time=2015-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26025, encodeId=d6452602589, content=热心期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Fri Jun 05 06:34:00 CST 2015, time=2015-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26009, encodeId=383e26009b3, content=太好了,期待!, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Thu Jun 04 19:55:00 CST 2015, time=2015-06-04, status=1, ipAttribution=)]
    2015-06-04 sumer

    太好了,期待!

    0

相关资讯

吃减肥药时会出现的稀奇事——《华盛顿邮报》

2007年,美国食品和药物管理局首次批准非处方减肥药。任何人无需处方便可购买这种名为Alli的减肥药。只要服用它的人依然保持健康的生活方式就可以达到减肥的目的。最后这一点可以说服服用减肥药的人坚持健康饮食,好好锻炼身体,这一点很重要但常常被很多减肥药所忽视。Alli制造商GlaxoSmithKline却意识到了这一点,而且它的营销广告也不会让人们觉得这是某种灵丹妙药。但要让人们相信这药只起辅助作用

父亲基因决定孩子健康 还能跨代传承?

据西班牙《万象》月刊5月号报道,“我们从祖先那里获得的DNA只是遗传的一个基础,重要的是这些基因如何表达,即我们继承的等位基因。我们的很多特征,例如眼睛和头发的颜色,受父母二人的影响是同等的,但有多达200种基因,是由其中一方决定的,包括导致多数常见病的基因以及所谓的‘基因印记’。这项研究的负责人之一、遗传学家费尔南多·帕尔多-曼奴埃尔·德比列纳指出。“我们的研究旨在查明这些基因中的每一种是由

当朝九晚五也可能有害健康时,肿么办?

可能你已经怀疑你上下班对你的健康没有任何好处,现在有确凿的科学证据能支持这一怀疑。一项新研究发现上下班的时间长短、距离远近以及上下班方式都能给我们造成压力。加拿大蒙特利尔大学的Annie Barreck表示这些因素综合起来,长久下去会令我们精疲力竭,她说:“通勤造成的压力因素和人们可能承受的筋疲力竭之间存在着相关性。但这种关联性会根据个人情况而发生变化,比如一个人出行时的路况和一个人工作的地点。”

JECH:“单身妈妈”的健康状况不容乐观

一提到单身母亲,大家想到最多的是什么?一个人带孩子的艰辛,一个人的孤苦无依受人欺负…等等,不仅如此,单身妈妈总是坏的健康状况如影随形紧密联系在一起。但是单身妈妈的健康状况在不同国家是否类似或一致目前尚不清楚,或许会存在某个国家其单身母亲健康快乐幸福生活一辈子,当然也或许全世界的单身妈妈的健康情况总体趋势是一致的。关于该问题,近期Berkman LF等人进行了一项研究,对不同国家包括美国、英国以及1

JECH:居住社区越穷,对健康危害越大

对于居无定所常常搬家的流动人口,在社会关系层面,居住的社区可能是影响身体健康的一大方面,贫穷的社区或许会对健康不利,但是不同的住宅区域周围有着不同的社区环境,因此对于社区的差异性则很大,而目前关于社区差异性因素对健康的影响的研究还很少。近期Jokela M等人进行了一项研究,探究同一个人在贫穷社区居住时身体健康状况是否会比在一个不那么穷的社区居住时更差。研究成果发表在近期《Journal of e

The Lancet:个体化医疗为健康带来巨大变化

在美国抑制心脏疾病的个体化医疗干预措施会带来1140亿美元的健康收益,近日一项发表于国际杂志The Lancet上的研究论文中,来自美国医学研究所的主席Victor Dzau表示,个体化及精准医学(PPM)的开发可以为美国人们的健康预期寿命带来巨大的进步,但PPM开发的动机目前相对薄弱。针对每一位患者的个体特征定制的PPM医学疗法会根据患者对特殊疾病的易感性来进行开发设计,但PPM远远超出了对患者